CORRECTING and REPLACING Vaxenta Inc. Announces Filing of International Patent for Novel Cancer Vaccine

03:20 EST 1 Jan 2014 | Businesswire
This article has expired, however you can still download the PDF.
Preview:
Biotechnology company leverages similarities between pregnancy and cancer in development of unique cancer immunotherapy treatment Please replace the release with the following corrected version due to multiple revisions. ...

Other Sources for this Article

Vaxenta Biotechnologies
Boris Markosian, CEO, 818-823–3632
Fax: 858-227–9774
Email: bmarkosi@vaxenta.com

NEXT ARTICLE

More From BioPortfolio on "CORRECTING and REPLACING Vaxenta Inc. Announces Filing of International Patent for Novel Cancer Vaccine"

Search BioPortfolio:
Advertisement

Relevant Topic

Women's Health
Latest News Clinical Trials Research Drugs Reports Corporate
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...

Advertisement

Searches Linking to this Story